| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.7M | +0.9% |
| Cost of Revenue | $20.8M | +49.9% |
| R&D Expense | $4.6M | +30.6% |
| SG&A Expense | $21.6M | +11.5% |
| Operating Income | -$21.5M | -102.9% |
| Pre-tax Income | -$20.6M | -120.9% |
| Income Tax | -$145K | +32.2% |
| Net Income | -$20.5M | -124.6% |
| EPS (Basic) | -$8.35 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.5M | -35.1% |
| Short-term Investments | $995K | -82.6% |
| Accounts Receivable | $6.0M | -31.4% |
| Inventory | $7.6M | -46.1% |
| Current Assets | $21.3M | -44.6% |
| Total Assets | $26.2M | -41.8% |
| Current Liabilities | $8.3M | +23.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.8M | +29.8% |
| Capital Expenditures | $519K | -25.6% |
| Investing Cash Flow | $4.5M | +166.9% |
| Financing Cash Flow | -$454K | +25.2% |
| Free Cash Flow | -$7.4M | +29.5% |
| -118.0% |
| EPS (Diluted) | -$8.35 | -118.0% |
| Total Liabilities |
| $9.0M |
| +11.9% |
| Stockholders' Equity | $17.2M | -53.5% |